DBV Technologies (CHIX:DBVP) Short Percentage of Float


CHIX:DBVP DBV Technologies SA CHIX:DBVP
31 GF Score
Price €2.91
! 1 Warning Sign
View Full Analysis

What is DBV Technologies Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CHIX:DBVP vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, DBV Technologies's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DBV Technologies Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DBV Technologies's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where DBV Technologies's Short Percentage of Float falls into.


CHIX:DBVP
31GF Score
DBV Technologies SA CHIX:DBVP
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DBV Technologies Business Description

Address 107 Avenue de la Republique, Batiment IRO, Chatillon, Paris, FRA, 92320
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
31GF Score

Get the complete analysis for CHIX:DBVP

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.91
Price